Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study page displays a 403 Forbidden message, and the site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T03:19:35.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the page, announcing updates and explaining that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T03:28:33.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T03:13:50.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T05:18:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record and indicating that access to the entry is blocked.
    Difference
    0.5%
    Check dated 2026-09-27T04:00:27.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    403 Forbidden error page is now shown, with a minimal header, replacing the study record content and navigation. This indicates an access restriction rather than an update to the core study information.
    Difference
    22%
    Check dated 2026-09-20T02:08:02.000Z thumbnail image

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.